Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
| dc.contributor.author | Hwang, Eu Chang | |
| dc.contributor.author | Gandhi, Shreyas | |
| dc.contributor.author | Jung, Jae Hung | |
| dc.contributor.author | Imamura, Mari | |
| dc.contributor.author | Kim, Myung Ha | |
| dc.contributor.author | Pang, Ran | |
| dc.contributor.author | Dahm, Philipp | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2019-10-10T23:04:43Z | |
| dc.date.available | 2019-10-10T23:04:43Z | |
| dc.date.embargoedUntil | 2019-10-11 | |
| dc.date.issued | 2018 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 1330355 | |
| dc.identifier | 140017695 | |
| dc.identifier | a3f15d7d-6188-43d3-90f8-b4834156d0d9 | |
| dc.identifier | 30306544 | |
| dc.identifier | 85055805733 | |
| dc.identifier.citation | Hwang, E C, Gandhi, S, Jung, J H, Imamura, M, Kim, M H, Pang, R & Dahm, P 2018, 'Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia', Cochrane Database of Systematic Reviews, no. 10, CD007360. https://doi.org/10.1002/14651858.CD007360.pub3 | en |
| dc.identifier.doi | 10.1002/14651858.CD007360.pub3 | |
| dc.identifier.iss | 10 | en |
| dc.identifier.issn | 1469-493X | |
| dc.identifier.uri | http://hdl.handle.net/2164/13095 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cochrane Database of Systematic Reviews | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia.pdf
- Size:
- 1.27 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
